Trials / Completed
CompletedNCT02705625
A Study to Evaluate the Efficacy, Safety and Tolerability of MIV-711 in Osteoarthritis Patients
A Randomised, Double-blind Placebo-controlled Phase IIa Study to Evaluate Efficacy, Safety and Tolerability of MIV-711 in Knee Joint Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 244 (actual)
- Sponsor
- Medivir · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicentre, randomised, placebo-controlled, double-blind, three-arm parallel, Phase IIa study to evaluate the efficacy, safety and tolerability of MIV-711 in patients with knee osteoarthritis (OA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MIV-711 | MIV-711 administered orally once daily |
| DRUG | Placebo | Placebo manufactured to mimic MIV-711 capsule. |
Timeline
- Start date
- 2016-01-28
- Primary completion
- 2017-05-23
- Completion
- 2017-05-23
- First posted
- 2016-03-10
- Last updated
- 2019-06-17
- Results posted
- 2019-06-17
Locations
6 sites across 6 countries: Bulgaria, Georgia, Germany, Moldova, Romania, United Kingdom
Source: ClinicalTrials.gov record NCT02705625. Inclusion in this directory is not an endorsement.